Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival

Transplant Proc. 1989 Feb;21(1 Pt 2):2385-8.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alprostadil / administration & dosage
  • Alprostadil / therapeutic use*
  • Aspartate Aminotransferases / blood
  • Blood Coagulation / drug effects
  • Catheterization, Central Venous
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Graft Survival / drug effects*
  • Humans
  • Infusions, Intravenous
  • Liver / drug effects
  • Liver / physiopathology
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Aspartate Aminotransferases
  • Alprostadil